NEW YORK, May 12, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, notifies investors of class action against DS Healthcare Group, Inc. ("DS Healthcare" or "the Company") (NASDAQ: DSKX). The class action has been filed on behalf of a class consisting of all persons or entities who purchased DS Healthcare from August 13, 2015 through March 23, 2016, inclusive (the "Class Period").
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").
The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) the unaudited financial statements for the two fiscal quarters ended June 30, 2015 and September 30, 2015 stated inappropriate revenues related to certain DS Healthcare customers, which did not meet revenue recognition criteria; (2) these same financial statements contained and failed to appropriately disclose certain equity transactions that were not in accordance with United States Generally Accepted Accounting Principles; (3) Defendant Daniel Khesin defied his fiduciary duty to DS Healthcare and its subsidiaries; and (4) consequentially, Defendants' statements DS Healthcare's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint and join the action, visit the firm's website: http://www.bgandg.com/#!dskx/ozv6l. To discuss this action, or have any questions, please contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in DS Healthcare you have until May 31, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-notifies-investors-of-class-action-against-ds-healthcare-group-inc-dskx-and-lead-plaintiff-deadline-may-31-2016-300266279.html
SOURCE Bronstein, Gewirtz & Grossman, LLC